Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by Dubbs777on Aug 24, 2018 10:18am
192 Views
Post# 28511455

News Today from EMH;

News Today from EMH;
News Today from EMH; "Emerald Health Therapeutics Engages Acorn Management Partners for Investor Relations VICTORIA, British Columbia, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (Emerald) today announced that it has engaged Acorn Management Partners, an Atlanta-based investor relations firm, to provide investor relations and communications services to the company, subject to TSX Venture Exchange acceptance. Acorn has been engaged for a one year term expiring July 29, 2019, and will be entitled to receive a monthly fee of $8,500 (U.S.). The agreement will automatically renew on a quarterly basis during the term and may be terminated by the company upon 30 days notice prior to the end of each quarter. Acorn currently has no direct or indirect interest in the securities of the company, or any right or intent to acquire such an interest. The appointment of Acorn as an investor relations consultant of the company remains subject to regulatory acceptance of applicable filings with the TSX Venture Exchange."
<< Previous
Bullboard Posts
Next >>